As of Jan 20
| -3.25 / -9.15%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 88.50, with a high estimate of 107.00 and a low estimate of 57.00. The median estimate represents a +174.42% increase from the last price of 32.25.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.